NATIONAL STOCK EXCHANGE OF INDIA LIMITED

DEPARTMENT : LISTING Download Ref. No.: NSE/CML/37954

Date : June 07, 2018

Circular Ref. No.: 0612/2018

To All Members, Sub: Monitoring of Foreign Investment limits in listed Indian companies – IL Series. In pursuance to SEBI circular no. IMD/FPIC/CIR/P/2018/61 dated April 5, 2018 regarding monitoring of Foreign Investment limits in listed Indian companies, the information relating to red flag and breaches of listed Indian companies furnished by depositories for dissemination date June 6, 2018. In view of the same, series- IL will be Activated/Suspended w.e.f. June 07, 2018 for the companies enclosed in Annexure I. For and on behalf of National Stock Exchange of India Limited

Kautuk Upadhyay Chief Manager Telephone No +91-22-26598235

Regd. Office: Exchange Plaza, Plot No. C/1, G-Block, Bandra-Kurla Complex, Bandra (E), Mumbai 400 051, India CIN: U67120MH1992PLC069769 Tel: +91 22 26598235/36 , 26598346, 26598459 /26598458 Web site: www.nseindia .com

Continuation Sheet

Annexure I Sr. No 1

Symbol ASTRAZEN

Company Name ASTRAZENECA PHARMA INDIA LIMITED

Remarks IL Suspension

2

Regd. Office: Exchange Plaza, Plot No. C/1, G-Block, Bandra-Kurla Complex, Bandra (E), Mumbai 400 051, India CIN: U67120MH1992PLC069769 Tel: +91 22 26598235/36 , 26598346, 26598459 /26598458 Web site: www.nseindia .com